SCHEMBL7698402

SCHEMBL7698402

CC(=O)NCC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1-c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 2/20 0.52
CHRNB4 P30926 2/20 0.52
CHRNA3 P32297 2/20 0.52
CHRNA4 P43681 2/20 0.52
TACR2 P21452 1/20 0.50
CAPN1 P07384 1/20 0.48
CLPP Q16740 2/20 0.46
ITGB1 P05556 2/20 0.45
ITGA4 P13612 2/20 0.45
ITGB7 P26010 2/20 0.45
HTT P42858 1/20 0.44
KMT2A Q03164 1/20 0.44
CTSS P25774 3/20 0.44
CTSK P43235 3/20 0.44
TACR3 P29371 1/20 0.43
KCNA5 P22460 1/20 0.43
CTSB P07858 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CTSL P07711 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7689953 0.88 CHRNB2 (0.52) CHRNB2CHRNB4CHRNA3CHRNA4TACR2
SCHEMBL7695358 0.83 CHRNB2 (0.47) CHRNB2CHRNB4CHRNA3CHRNA4TACR2
SCHEMBL7657278 0.83 CLPP (0.44) CHRNB2CHRNB4CHRNA3CHRNA4TACR2
SCHEMBL7694696 0.81 KDM4E (0.47) ITGB1ITGA4ITGB7HTTKMT2A
SCHEMBL7690823 0.81 CAPN1 (0.60) CAPN1KMT2ACTSSCTSKCTSB
SCHEMBL7704469 0.80 KCNA5 (0.52) CHRNB2CHRNB4CHRNA3CHRNA4TACR2
SCHEMBL3641713 0.79 CAPN1 (0.60) CHRNB2CHRNB4CHRNA3CHRNA4TACR2
SCHEMBL3642696 0.79 CAPN1 (0.60) CHRNB2CHRNB4CHRNA3CHRNA4TACR2
SCHEMBL3642692 0.79 CAPN1 (0.60) CHRNB2CHRNB4CHRNA3CHRNA4TACR2
SCHEMBL6939927 0.78 CAPN1 (0.55) CHRNB2CHRNB4CHRNA3CHRNA4TACR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed